Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility

NeuroImage

Volumn 48, Issue 2, 2009, Pages 329-338

  Edison, Paul ^a   Brooks, David J ^a,d   Turkheimer, Federico E ^a   Archer, Hilary A ^b   Hinz, Rainer ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d GE HEALTHCARE   (United Kingdom)

Author keywords

11C PIB; Amyloid; Positron emission tomography; Quantification; Reference region; Tracer kinetic modelling

Indexed keywords

CARBON 11;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PARAMETRIC TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SPECTROSCOPY; STUDENT T TEST; TEST RETEST RELIABILITY;

AGED; ALZHEIMER DISEASE; ANILINE COMPOUNDS; BRAIN; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; THIAZOLES; TIME FACTORS;

EID: 68749114058     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.06.079     Document Type: Article

References (43)

1. Asselin M.C., Montgomery A.J., Grasby P.M., and Hume S.P. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J. Cereb. Blood Flow Metab. 27 (2007) 378-392
2. Bacskai B.J., Hickey G.A., Skoch J., Kajdasz S.T., Wang Y., Huang G.F., Mathis C.A., Klunk W.E., and Hyman B.T. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12462-12467
3. Blomquist G., Hinz R., Engler H., Nordberg A., and Langstrom B. Different patterns of PIB uptake in AD patients. J. Cereb. Blood Flow Metab. 25 (2005) S666
4. Blomquist G., Englar H., Nordberg A., Ringheim A., Wall A., Forsberg A., Estrada M., Frandberg P., Antoni G., and Langstrom B. Unidirectional influx and net accumulation of PIB. The Open Neuroimaging Journal 2 (2008) 114-125
5. Brix G., Zaers J., Adam L.E., Bellemann M.E., Ostertag H., Trojan H., Haberkorn U., Doll J., Oberdorfer F., and Lorenz W.J. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J. Nucl. Med. 38 (1997) 1614-1623
6. Collignon A., Maes F., Delaere D., Vandermeulen D., Suetens P., and Marchal G. Automated multi-modality image registration based on information theory. In: Bizais Y., Barillot C., and Di Paola R. (Eds). Proceedings of the International Conference on Information Processing in Medical Imaging (1995), Kluwer Academic Publishers, Dordrecht, The Netherlands 263-274
7. Cunningham V.J., and Jones T. Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab. 13 (1993) 15-23
8. Defrise M., Kinahan P.E., Townsend D.W., Michel C., Sibomana M., and Newport D.F. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans. Med. Imaging 16 (1997) 145-158
9. Edison P., Archer H.A., Hinz R., Hammers A., Pavese N., Tai Y.F., Hotton G., Cutler D., Fox N., Kennedy A., Rossor M., and Brooks D.J. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68 (2007) 501-508
10. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 6 (1997) 279-287
11. Hammers A., Chen C.H., Lemieux L., Allom R., Vossos S., Free S.L., Myers R., Brooks D.J., Duncan J.S., and Koepp M.J. Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space. Hum. Brain Mapp. 28 (2007) 34-48
12. 11C]diprenorphine test-retest data. NeuroImage 38 (2007) 82-94
13. Hinz R., and Turkheimer F.E. Determination of tracer arrival delay with spectral analysis. IEEE Trans. Nucl. Sci. 53 (2006) 212-219
14. 11C]PIB studies using spectral analysis. J Cereb Blood Flow Metab 25 (2005) S590
15. Hinz R., Blomquist G., Edison P., and Brooks D.J. Simplified analysis of [11C]PIB images in Alzheimer's disease patients and control subjects. J Nucl Med 46 (2005) 456P-457P
16. Kaufer I.D., Yuen H., DeKosky S., and Klunk W. Cerebellar amyloid in a case of early-onset dementia with a presenilin-1 mutation: correlation to clinical phenotype. Alzheimer's and Dementia 4 (2008) T290-T291
17. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., and Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69 (2001) 1471-1484
18. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., and Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
19. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., MacGregor R.R., Hitzemann R., Bendriem B., Gatley S.J., et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10 (1990) 740-747
20. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., and Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16 (1996) 834-840
21. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., Meltzer C.C., Schimmel K., Tsopelas N.D., Dekosky S.T., and Price J.C. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 46 (2005) 1959-1972
22. Lubberink M., Van Berckel B.N.M., Luurtsema G., Takkenkamp K., Tolboom N., Yaqub M., and Lammertsma A.A. Multi-input spectral analysis for assessing cerebral uptake of labelled metabolites: validation and application to [11C]PIB and [18F]FDDNP studies. J. Cereb. Blood Flow Metab. 27 (2007) PS01-05M
23. Luthra S.K., Osman S., Turton D.R., Vaja V., Dowsett K., and Brady F. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged [11C]-l-deprenyl; [11C]diprenrophine; [11C]flumazenil; [11C]raclopride; and [11C]Scherring 23390. J. Lab. Comp. Radiopharm. 32 (1993) 518-520
24. Mathis C.A., Bacskai B.J., Kajdasz S.T., McLellan M.E., Frosch M.P., Hyman B.T., Holt D.P., Wang Y., Huang G.F., Debnath M.L., and Klunk W.E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 12 (2002) 295-298
25. Mathis C.A., Wang Y., Holt D.P., Huang G.F., Debnath M.L., and Klunk W.E. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 46 (2003) 2740-2754
26. Mathis C.A., Wang Y., and Klunk W.E. Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr. Pharm. Des. 10 (2004) 1469-1492
27. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
28. Mead S., Poulter M., Beck J., Webb T.E., Campbell T.A., Linehan J.M., Desbruslais M., Joiner S., Wadsworth J.D., King A., Lantos P., and Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129 (2006) 2297-2317
29. 11C-PIB scans for diagnosing Alzheimer's Disease. J. Nucl. Med. 49 (2008) 1262-1269
30. Mourik J.E., Lubberink M., Schuitemaker A., Tolboom N., van Berckel B.N., Lammertsma A.A., and Boellaard R. Image-derived input functions for PET brain studies. Eur. J. Nucl. Med. Mol. Imaging 36 (2009) 463-471
31. 18F-FDG PET for detection of Alzheimer's disease. J. Nucl. Med. 48 (2007) 547-552
32. Patlak C.S., and Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 5 (1985) 584-590
33. Patlak C.S., Blasberg R.G., and Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3 (1983) 1-7
34. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., Holt D.P., Meltzer C.C., DeKosky S.T., and Mathis C.A. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 25 (2005) 1528-1547
35. Ranicar A.S., Williams C.W., Schnorr L., Clark J.C., Rhodes C.G., Bloomfield P.M., and Jones T. The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Med. Prog. Technol. 17 (1991) 259-264
36. 11C]PIB studies in Alzheimer's disease. Eur. J. Nucl. Med. Mol Imaging 36 (2009) (electronic publication ahead of print)
37. Turkheimer F., Moresco R.M., Lucignani G., Sokoloff L., Fazio F., and Schmidt K. The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures. J. Cereb. Blood Flow Metab. 14 (1994) 406-422
38. Wang Y., Klunk W.E., Huang G.F., Debnath M.L., Holt D.P., and Mathis C.A. Synthesis and evaluation of 2-(3′-iodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease. J. Mol. Neurosci. 19 (2002) 11-16
39. Watanabe R., and Duchen L.W. Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 19 (1993) 253-260
40. Wu Y., and Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 22 (2002) 1440-1452
41. 11C] PIB studies. NeuroImage 42 (2008) 76-86
42. Zhou Y., Resnick S.M., Ye W., Fan H., Holt D.P., Klunk W.E., Mathis C.A., Dannals R., and Wong D.F. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. NeuroImage 36 (2007) 298-312
43. Ziolko S.K., Weissfeld L.A., Klunk W.E., Mathis C.A., Hoge J.A., Lopresti B.J., DeKosky S.T., and Price J.C. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. NeuroImage 33 (2006) 94-102